mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.075 |
0.8 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |